Junto Capital Management LP Sells 54,965 Shares of Cardinal Health, Inc. $CAH

Key Points

• Junto Capital Management LP reduced its stake in Cardinal Health, Inc. by 7.0%, owning 729,771 shares following the sale of 54,965 shares during the first quarter.
• Insider selling has been notable, with CEO Jason M. Hollar selling 107,705 shares worth over $16 million, indicating a 31.35% decrease in his holdings.
• Cardinal Health recently announced a quarterly dividend of $0.5107 to be paid on October 15th, representing an annualized yield of 1.4%.

Junto Capital Management LP decreased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 7.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 729,771 shares of the company's stock after selling 54,965 shares during the quarter. Cardinal Health accounts for about 2.1% of Junto Capital Management LP's investment portfolio, making the stock its 9th largest holding. Junto Capital Management LP owned 0.31% of Cardinal Health worth $100,541,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health in the 1st quarter valued at $26,000. Tompkins Financial Corp lifted its stake in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after acquiring an additional 128 shares in the last quarter. GW&K Investment Management LLC lifted its stake in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after acquiring an additional 144 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new stake in Cardinal Health in the 4th quarter worth about $36,000. Finally, NBC Securities Inc. purchased a new stake in Cardinal Health in the 1st quarter worth about $48,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CAH shares. Robert W. Baird increased their price objective on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research note on Tuesday, August 12th. Argus set a $189.00 price objective on Cardinal Health in a research note on Friday, August 22nd. Finally, UBS Group reissued a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Stock Down 0.9%

Shares of CAH traded down $1.43 during midday trading on Thursday, reaching $149.14. 876,605 shares of the stock were exchanged, compared to its average volume of 2,411,984. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44. The firm has a 50 day simple moving average of $156.54 and a 200-day simple moving average of $146.51. The company has a market cap of $35.61 billion, a price-to-earnings ratio of 23.10, a P/E/G ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the business earned $1.84 EPS. The business's quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio is currently 31.63%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares in the company, valued at $2,228,728.32. This trade represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last 90 days. Company insiders own 0.09% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.